BRAFV600E mutation is associated with better prognoses in radioactive iodine refractory thyroid cancer patients treated with multi-kinase inhibitors: a retrospective analysis of registered clinical trials.
Saved in:
| Title: | BRAFV600E mutation is associated with better prognoses in radioactive iodine refractory thyroid cancer patients treated with multi-kinase inhibitors: a retrospective analysis of registered clinical trials. |
|---|---|
| Authors: | Sun, Di1,2 (AUTHOR), Zhang, Xin1,2 (AUTHOR), Jin, Xiaona1,2 (AUTHOR), Shi, Cong1,2 (AUTHOR), Sun, Yuqing1,2 (AUTHOR), Zhang, Yingqiang1,2 (AUTHOR), Liang, Jun3,4 (AUTHOR) liangjun1959@aliyun.com, Lin, Yansong1,2 (AUTHOR) linys@pumch.cn |
| Source: | Thyroid Research. 2/10/2025, Vol. 18 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
